Stay updated with breaking news from Peripheralt Cell Lymphomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response in r/r Peripheral T-cell Lymphomas ; ORR in r/r PTCL Patients with Standard of Care is 25.8% - - One Patient...
- SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response (ORR) in r/r Peripheral T-cell Lymphomas (PTCL); ORR in r/r PTCL...
/PRNewswire/ -- Owen A. O'Connor, M.D., Ph.D., is being recognized by Continental Who's Who as a Most Trusted Healthcare Provider and for his contributions in...
Summary Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3. 5. ...
/PRNewswire/ -- Owen A. O'Connor, M.D., Ph.D., is being recognized by Continental Who's Who as a Top Pinnacle Achiever for inventing and developing many drugs...